School
Giza, Egypt
NCT Number: NCT04485312
Adolescent Special need individuals are most need of easy forms of antibacterial agents, so in this study, using chemotherapeutic agents like the newly introduced varnish containing chlorhexidine seems to be a quite promising tool for local delivery to patients with special needs . Chlorhexidine is a wide spectrum very effective bactericidal used for years against the oral flora while fluorides are well known with their antibacterial ability. This may be an excellent way to reduce the risk assessment in adolescent special needs patients.
Looking for future studies?
Notify Me13 year–18 year
All sexes
Interventional
Not applicable
Giza, Egypt
Participants will be divided into two groups according to the tested regimen, where (A1) represents participants exposed to risk based conventional protocol, (A2) represents participants exposed to chlorhexidine containing varnish and risk based conventional preventive protocol. The study will be carried over a period of 10 months (one academic year), the study will be divided into three phases Phase I: Information of the Cariogram parameters (caries experience, diet content, diet frequency, plaque amount, mutans streptococci, fluoride program, saliva secretion and saliva buffer capacity) will be collected, which will be used to generate the individual caries profile, based on which the participants will be divided into 2 risks groups. Phase II: Risk based preventive program will be implemented including the restorative part. Phase III: At the end of 10 months, caries profile will be generated again
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
preventive protocol
chlorhexidine varnish added to the preventive protocol
Time frame: 10 months
% of the green sector in the cariogram
Cairo University
Other
Chance to Avoid New Caries by Adding Chlorhexidine Containing Chemotherapeutic Agent to the Conventional Preventive Protocol for Patients With Special Needs
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05379504
Disabilities Multiple, Quality of Life
Columbia, Missouri, United States
View Trial DetailsNCT06075797
Brain Damage, Chronic, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT04999085
Blood Protein Disorders, Cardiovascular Diseases
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05374811
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Istanbul, Turkey (Türkiye)
View Trial Details